Protein kinases JAK and ERK mediate protective effect of interleukin-2 upon ganglion cells of the developing rat retina

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 120-126

  Marra, Camila ^a   Gomes Moret, Denise ^a   de Souza Corrêa, Amanda ^a   Chagas da Silva, Fernanda ^a   Moraes, Patrícia ^a   Linden, Rafael ^a   Sholl Franco, Alfred ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Axotomy; Central nervous system; Cytokines; Development; Retina; Retinal ganglion cells

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; IN VITRO STUDY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA NERVE CELL; SIGNAL TRANSDUCTION;

EID: 79953306814     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.12.008     Document Type: Article

References (55)

1. Almeida R.D., Manadas B.J., Melo C.V., Gomes J.R., Mendes C.S., Grãos M.M., Carvalho R.F., Carvalho A.P., Duarte C.B. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 2005, 12:1329-1343.
2. Araújo D.M., Lapchak P.A., Collier B., Quirion R. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 1989, 498:257-266.
3. Awatsuji H., Furukawa Y., Nakajima M., Furukawa S., Hayashi K. Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J. Neurosci. Res. 1993, 35:305-311.
4. Beck R.D., King M.A., Huang Z., Petitto J.M. Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout. Brain Res. 2002, 955:16-23.
5. Beck R.D., Wasserfall C., Ha G.K., Cuschman J.D., Huang Z., Atkinson M.A., Petitto J.M. Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res. 2005, 1041:223-230.
6. Beck R.D., King M.A., Ha G.K., Cushman J.D., Huang Z., Petitto J.M. IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins. J. Neuroimmunol. 2005, 160:146-153.
7. Buss R.R., Sun W., Oppenheim R.W. Adaptative roles of programmed cell death during nervous system development. Annu. Rev. Neurosci. 2006, 29:1-35.
8. Chen H., Weber A.J. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest. Ophthalmol. Vis. Sci. 2001, 42:966-974.
9. Crespo D., O'Leary D.D., Cowan W.M. Changes in the numbers of optic nerve fibers during late prenatal and postnatal development in the albino rat. Brain Res. 1985, 351:129-134.
10. Ellery J.M., Nicholls P.J. Alternate signaling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev. 2002, 13:27-40.
11. Erlich R.B., Werneck C.C., Mourão P.A.S., Linden R. Major glycosaminoglycan species in the developing retina: synthesis, tissue distribution and effects upon cell death. Exp. Eye Res. 2003, 77:157-165.
12. Fan W., Agarwal N., Cooper N.G.F. The role of CAMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5). Brain Res. 2006, 1067:48-57.
13. Farah M.H. Neurogenesis and cell death in the ganglion cell layer of vertebrate retina. Brain Res. Rev. 2006, 52:264-274.
14. Fujiwara T., Oda K., Yokota S., Takatsuki A., Ikehara Y. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 1988, 263:18545-18552.
15. Fung M.M., Rohwer F., McGuire K.L. IL-2 activation of a PI3-K-dependent STAT3 serine phosphorylation pathway in primary human T cells. Cell. Signal. 2003, 15:625-636.
16. Galli-Resta L., Ensini M. An intrinsic time limit between genesis and death of individual neurons in the developing retinal ganglion cell layer. J. Neurosci. 1996, 16:2318-2324.
17. Garg S.K., Banerjee R., Kipnis J. Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype. J. Immunol. 2008, 180:3866-3873.
18. Gómez J., García A., R-Borlado L., Bonay P., Martínez-A C., Fresno M., Carrera A.C., Eicher-Streiber C., Rebollo A. IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta. J. Immunol. 1997, 158:1516-1522.
19. Hanisch U.K., Seto R., Quirion R. Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J. Neurosci. 1993, 13:3368-3374.
20. Hooks J.J., Chan C.C., Detrick B. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest. Ophtalmol. Vis. Sci. 1988, 29:1444-1451.
21. Hu B., Nikolakopoulou A.M., Cohen-Cory S. BDNF stabilizes synapses and maintains the structural complexity of optic axons in vivo. Development 2005, 132:4285-4298.
22. Huang Y., Cen L.P., Choy K.W., Van Rooijen N., Wang N., Pang C.P., Cui Q. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions. Exp. Eye Res. 2007, 85(5):684-695.
23. Huang Y., Li Z., Wang N., van Rooijen N., Cui Q. Roles of PI3K and JAK pathways in viability of retinal ganglion cells after acute elevation of intraocular pressure in rats with different autoimmune backgrounds. BMC Neurosci. 2008, 11:9-78.
24. Kermer P., Klöcker N., Labes M., Bähr M. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI-3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. J. Neurosci. 2000, 20:722-728.
25. Kilic U., Kilic E., Jarve A., Guo Z., Spudich A., Bieber K., Barzena U., Basseti C.L., Marti H.H., Hermann D.M. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 2006, 26:12439-12446.
26. Koeberle P.D., Gauldie J.E., Ball A.K. Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells. Neuroscience 2004, 125:903-920.
27. Kono T., Minami Y., Taniguchi T. The interleukin-2 receptor complex and signal transduction: role of the beta-chain. Semin. Immunol. 1993, 5:299-307.
28. Létourneau S., Krieg C., Pantaleo G., Boyman O. IL-2 and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets. J. Allergy Clin. Immunol. 2009, 123:758-762.
29. Linden R., Rehen S.K., Chiarini L.B. Apoptosis in developing retinal tissue. Prog. Retin. Eye Res. 1999, 18:133-165.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
31. Minami Y., Taniguchi T. IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr. Opin. Neurobiol. 1995, 7:156-162.
32. Nakazawa T., Tamai M., Mori N. Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest. Ophthalmol. Vis. Sci. 2002, 43:3319-3326.
33. Osborne N.N., Chidlow G., Layton C.J., Wood J.P., Casson R.J., Melena J. Optic nerve and neuroprotection strategies. Eye 2004, 18:1075-1084.
34. Oshitari T., Yoshida-Hata N., Yamamoto S. Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose. Brain Res. 2010, 1346:43-51.
35. Otero G.C., Merrill J.E. Response of human oligodendrocytes to interleukin-2. Brain Behav. Immun. 1997, 11:24-38.
36. Pernet V., Di Polo A. Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo. Brain 2006, 129:1014-1026.
37. Pernet V., Hauswirth W.W., Di Polo A. Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J. Neurochem. 2005, 93:72-83.
38. Perry V.H., Henderson Z., Linden R. Postnatal changes in retinal ganglion cell and optic axon populations in the pigmented rat. J. Comp. Neurol. 1983, 219:356-368.
39. Petitto J.M., Huang Z. Cloning the full-length IL-2/15 receptor-beta cDNA sequence from mouse brain: evidence of enrichment in hipocampal formation neurons. Regul. Pept. 2001, 98:77-87.
40. Rehen S.K., Varella M.H., Freitas F.G., Moraes M.O., Linden R. Contrasting effects of protein synthesis inhibition and of cyclic AMP on apoptosis in the developing retina. Development 1996, 122:1439-1448.
41. Saneto R.P., Altman A., Knobler R.L., Johnson H.M., de Vellis J. Inteleukin-2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc. Natl. Sci. U. S. A. 1986, 83:9221-9225.
42. Sappington R.M., Chan M., Calkins D.J. Interleukin-6 protects retinal ganglion cells from pressure-induced death. Invest. Ophtalmol. Vis. Sci. 2006, 47:2932-2942.
43. Sarder M., Saito H., Abe K. Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain. Brain Res. 1993, 625:347-350.
44. Sarder M., Abe K., Saito H., Nishiyama N. Comparative effect of IL-2 and IL-6 on morphology of cultured hippocampal neurons from fetal brain. Brain Res. 1996, 715:9-16.
45. Seigel G.M. The golden age of retinal cell culture. Mol. Vis. 1999, 5:4-13.
46. Shen Y., Zhu L.J., Liu S.S., Zhou S.Y., Luo J.H. Interleukin-2 inhibits NMDA receptor-mediated currents directly and may differentially affect subtypes. Biochem. Biophys. Res. Commun. 2006, 351:449-454.
47. Shen Y., Liu S.S., Zhan M.Y., Luo J.H., Zhu L.J. Interleukin-2 enhances dendritic development and spinogenesis in cultured hippocampal neurons. Anat. Rec. 2010, 293:1017-1023.
48. Shimojo M., Imai Y., Nakajima K., Mizushima S., Uemura A., Kohsaka S. Interleukin-2 enhances the viability of primary cultured rat neocortical neurons. Neurosci. Lett. 1993, 151(2):170-173.
49. Sholl-Franco A., Figueiredo K.G., de Araújo E.G. Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture. NeuroReport 2001, 12:109-112.
50. Sholl-Franco A., Marques P.M., Paes-de-Carvalho R., de Araujo E.G. Antagonistic and synergistic effects of combined treatment with interleukin-2 and interleukin-4 on mixed retinal cell cultures. J. Neuroimmunol. 2001, 113(1):40-48.
51. Silva A.G., Campello-Costa P., Linden R., Sholl-Franco A. Interleukin-4 blocks proliferation of retinal progenitor cells and increases rod photoreceptor differentiation through distinct signalling pathways. J. Neuroimmunol. 2008, 30:82-93.
52. Strom R.C., Williams R.W. Cell production and cell death in the generation of variation in neuron number. J. Neurosci. 1998, 18:9948-9953.
53. Wang G., Lu C., Liu H., Jin W., Jiao X., Wei G., Chen J., Zhu Y. Immunohistochemical localization of interleukin-2 and its receptor subunits α, β e γ in the main olfactory bulb of the rat. Brain Res. 2001, 893:244-252.
54. Zhang C., Li H., Liu M.G., Kawasaki A., Fu X.Y., Barnstable C.J., Zhang S.S.M. STAT3 activation protects retinal ganglion cell layer neurons in response to stress. Exp. Eye Res. 2008, 86(6):991-997.
55. Zhou Y., Pernet V., Hauswirth W.W., Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol. Ther. 2005, 12:402-412.